Health Care Distributors

Pomdoctor

Pomdoctor released FY2025 Annual Earnings on May 14, 2026 (EST) with actual revenue of USD 56.05 M and EPS of USD -0.513

Pomdoctor released FY2025 9 Months earnings on May 14 (EST), actual revenue USD 40.01 M, actual EPS USD -0.3903

Pomdoctor released FY2025 Q4 earnings on May 14 (EST), actual revenue USD 16.11 M, actual EPS USD -0.128

Pomdoctor released FY2025 Q3 earnings on May 14 (EST), actual revenue USD 15.83 M, actual EPS USD -0.1258

Pomdoctor released FY2025 Q1 earnings on December 3, 2025 (EST), with actual revenue of USD 12.01 M and EPS of USD -0.1314

Pomdoctor released FY2025 Semi-Annual Earnings on December 3, 2025 (EST), with actual revenue of USD 24.17 M and EPS of USD -0.2645

Pomdoctor released FY2025 Q2 earnings on December 3, 2025 (EST), actual revenue USD 12.16 M, actual EPS USD -0.1331

POMDOCTOR LIMITED Exercised Greenshoe Option Fully, Raising Additional $23 Million

Pomdoctor released FY2023 Q3 earnings on March 31, 2025 (EST), with actual revenue of USD 12.12 M and EPS of USD -0.0948

Pomdoctor released FY2024 Annual Earnings on March 31 Post-Market (EST), actual revenue USD 47.58 M, actual EPS USD -0.5259

Pomdoctor released FY2023 Annual Earnings on March 31, 2025 (EST) with actual revenue of USD 42.75 M and EPS of USD -0.5384

Pomdoctor released FY2023 9 Months Earnings on March 31 (EST), actual revenue USD 30.21 M, actual EPS USD -0.5273

Pomdoctor released FY2023 Q4 earnings on March 31 (EST), actual revenue USD 12.47 M, actual EPS USD -0.0975

Pomdoctor released FY2024 Q3 earnings on March 31 (EST), actual revenue USD 13.72 M, actual EPS USD -0.1061

Pomdoctor released FY2024 9 Months Earnings on March 31, 2025 (EST), actual revenue USD 34.45 M, actual EPS USD -0.4859

Pomdoctor released FY2024 Q4 earnings on March 31 (EST), actual revenue USD 13.18 M, actual EPS USD -0.102

Pomdoctor released FY2024 Semi-Annual earnings on March 13, 2025 (EST), with actual revenue of USD 20.73 M and actual EPS of USD -0.3797

Pomdoctor released FY2022 Q3 earnings on March 13, 2025 (EST), with actual revenue of USD 9.481 M and EPS of USD -0.1687

Pomdoctor released FY2023 Q1 earnings on March 13, 2025 (EST), actual revenue USD 9.297 M, actual EPS USD -0.2222

Pomdoctor released FY2022 Annual Earnings on March 13, 2025 (EST), Actual Revenue: USD 36.23 M, Actual EPS: USD -0.7645

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

PomDoctor Ltd. reported a 16.7% increase in fiscal 2025 revenues to RMB399.9 million, driven by a 69.3% rise in Internet hospital revenue. However, the company faced a wider net loss of RMB130.9 million due to increased spending on sales, administration, and R&D, including IPO costs. R&D investment surged by 328.5%, focusing on AI and healthcare. Despite the revenue growth, Spark's AI Analyst rates POM as Neutral due to weak financial fundamentals and bearish technical momentum. PomDoctor operates an Internet hospital platform in China, specializing in chronic disease management.

Tip Ranks

Pomdoctor Posts Strong 2025 Revenue Growth but Wider Loss as IPO and R&D Spending Climb

POMDOCTOR LIMITED Announces Fiscal Year 2025 Financial Results | POM Stock News

StockTitan

POMDOCTOR LIMITED Announces Fiscal Year 2025 Financial Results | POM Stock News

Pomdoctor fell 18.84%; McKesson rose 1.15%, with a transaction volume of USD 190 million; Cencora rose 1.15%, with a transaction volume of USD 133 million; Cardinal Health rose 0.64%, with a transaction volume of USD 99.54 million; Henry Schein rose 1.17%, with a market value of USD 7.951 billion

Price Alert

McKesson

Cencora

Cardinal Health

Henry Schein

U.S. stock market midday update: Pomdoctor fell 18.84%, trading volume increased, market sentiment fluctuations have drawn attention, and future trends need to be observed cautiously

HRTX

DRTS

CNSP

CODX

In Monday's trading session, several health care stocks experienced significant movements. Pomdoctor (POM) surged 185.9% to $0.21, while Intelligent Bio Solutions (INBS) rose 35.59% to $3.2. Other gainers included Odysight ai (ODYS) up 26.0% to $5.62, Exagen (XGN) up 24.74% to $3.68, and Alpha Tau Medical (DRTS) up 22.32% to $10.41. Conversely, WORK Medical Tech Gr (WOK) fell 33.3% to $0.85, Co-Diagnostics (CODX) dropped 23.72% to $1.93, and Heron Therapeutics (HRTX) decreased 22.04% to $0.94. Bristol-Myers Squibb (CELGR) shares fell 18.32% to $0.11, while Certara (CERT) declined 18.15% to $5.17. CNS Pharmaceuticals (CNSP) also saw a drop of 17.29% to $6.03.

benzinga_article

Heron Therap

Bristol Myers Squibb

Alpha Tau Medical

CNS Pharma

Exagen

Co-Diagnostics

Intelligent Bio Solutions

Odysight.ai

Lexicon Pharma

WORK Medical Tech

Bristol-Myers Squibb Company

Certara

ALPHA TAU MEDICAL LTD C/WTS (TO PUR COM)

12 Health Care Stocks Moving In Monday's Intraday Session

ENHA

Pomdoctor pre-market up 18.53%; Enhanced pre-market down 12.99%; Yidianxing pre-market up 101.75%; Helport AI pre-market up 58.23%; Everspin Technology pre-market up 38.76%

Enhanced

EZGO Tech

Helport AI

Everspin Tech

Pre-market hot trades in US stocks: Pomdoctor up 18.53% in pre-market; Enhanced down 12.99% in pre-market

Overview of the US Stock Market The current market shows a clear trend of differentiation, with technology stocks and small-cap stocks performing particularly well. Notably, Rackspace Tech surged by 61.65%, attracting a significant inflow of funds and indicating an increase in short-term enthusiasm. Meanwhile, Pomdoctor's plummet of 82.83% has drawn widespread attention from the market, with trading volume significantly increasing, reflecting intense fluctuations in investor sentiment. Overall, the market pace is fast, with funds frequently switching between different sectors and active short-term trading. In the past hour, the most volatile stock, Rackspace Tech, stood out in the market, with a rise of 61.65% and a substantial increase in trading volume, indicating strong buying support. The stock's increase seems to be driven by market expectations of a rebound in cloud computing demand, with short-term sentiment running high and attracting considerable investor interest. Strong stocks: 1. Co-Diagnostics: up 39.37%, with a 10-day increase of 50.90%, showing strong market demand. 2. Fundrise Innovation Fund LLC: up 31.75%, with a year-to-date increase of 511.10%, and continued strong fund inflow. 3. Rocket Lab: up 31.09%, reaching a new 52-week high, with the market full of confidence in its future development prospects

Rackspace Tech

Republic Power

K&F GROWTH ACQUISITION CORP II COM USD0.0001 CL A 29/08/2031 (SUBS/RTS)

AIM ImmunoTech

Smart Powerr

Semilux

Fundrise Innovation Fund LLC

Rocket Lab

Phoenix Asia

Fluence Energy

Star Fashion Culture

Accuray

Akamai Tech

Akanda

Fitness Champs

Meridian

Waldencast

3 E Network Tech

Firefly Aerospace

CloudFlare

EOS Energy Enterprises

Skycorp Solar

GLOBA TERRA ACQUISITION CORPORATION COM USD0.0001 CL A (SUB/RTS)17/06/2030

Intuitive Machines

BlackSky Tech

Real Messenger

Maxlinear

Destiny Tech100

HubSpot

Redwire

Chanson

Lifetime Brands

Aspire Biopharma

Masterbeef

Teads

Zepp Health

Direct Digital

Nexentis Tech

Global Engine

Xiao I

Atara Biotherap

Lichen

Sandisk

Senestech

Commerce.com

Neonc Tech

Sidus Space

Bakkt

Clean Energy Tech

Toast

Canadian Solar

Gauzy

Micron Tech

Intel

AST SpaceMobile

Happy City

Monster Beverage

Navitas Semiconductor

Aehr Test

Alpha Tech

Leslies

Dell Tech

POET Tech

Volato

Mercadolibre

Xanadu Quantum Tech - B

Planet Labs

Zevia PBC

Rain Enhancement Tech Holdco 

E-Power

Coreweave

enGene Therapeutics

agilon health

Natera

Motorola Solution

Moderna

Himax Tech

Octave Specialty

Jumia Tech AG 

Lightwave Logic

FabricAI

Ubiquiti

Humana

Rocket

ENvue Medical

BTCS

Faraday Future Intelligent Electric

Sobr Safe

Allbirds

eLong Power

SoundHound AI

GD Culture

U.S. Stock Movement Update: U.S. stocks experience significant volatility, Rackspace Tech rises 61.65%, Pomdoctor falls 82.83%

CVGI

SKYX

In Wednesday's trading session, BlueLinx Holdings (NYSE:BXC) saw a significant gain of 28.8%, reaching $59.5, following its Q1 earnings report. Other notable gainers included SKYX Platforms (NASDAQ:SKYX) up 26.38%, Commercial Vehicle Group (NASDAQ:CVGI) up 24.17%, and GEO Group (NYSE:GEO) up 23.31%. Conversely, Primoris Services (NYSE:PRIM) experienced a sharp decline of 50.6% to $100.14, along with Limbach Holdings (NASDAQ:LMB) down 35.14% and Phoenix Asia Holdings (NASDAQ:PHOE) down 33.74%.

Bluelinx

Commercial Vehicle

SKYX Platforms

NANO Nuclear Energy

Primoris

Limbach

Cre8 Enterprise - CL

Globavend

Broadwind

12 Industrials Stocks Moving In Wednesday's Intraday Session

PomDoctor Limited has announced a delay in filing its annual Form 20-F for the year ended December 31, 2025, due to the need for additional time to review its consolidated financial statements. The company expects to file the report within 15 days of the original SEC due date. PomDoctor emphasizes that this delay is not related to any issues with auditors or internal controls. The company anticipates no significant changes in its financial results, although final numbers may vary after the audit. The notification is signed by CEO Zhenyang Shi, indicating executive responsibility for compliance.

PomDoctor Limited Delays Annual 20-F Filing

HCWB

AXGN

In Tuesday's pre-market session, several health care stocks experienced significant movements. Notable gainers included Pomdoctor (POM) with a 30.4% rise to $0.39, Omnicell (OMCL) up 23.3% to $46.4, and Axogen (AXGN) increasing by 12.97% to $44.5. Conversely, Soligenix (SNGX) saw a sharp decline of 51.7% to $0.68, while Erasca (ERAS) fell 43.29% to $10.86. Other notable losers included iTonic Holdings (ITOC) down 13.34% and HCW Biologics (HCWB) down 12.62%.

Pomdoctor(POM.US)

Pomdoctor Posts Strong 2025 Revenue Growth but Wider Loss as IPO and R&D Spending Climb

POMDOCTOR LIMITED Announces Fiscal Year 2025 Financial Results | POM Stock News

U.S. stock market midday update: Pomdoctor fell 18.84%, trading volume increased, market sentiment fluctuations have drawn attention, and future trends need to be observed cautiously

12 Health Care Stocks Moving In Monday's Intraday Session

Pre-market hot trades in US stocks: Pomdoctor up 18.53% in pre-market; Enhanced down 12.99% in pre-market

U.S. Stock Movement Update: U.S. stocks experience significant volatility, Rackspace Tech rises 61.65%, Pomdoctor falls 82.83%

12 Industrials Stocks Moving In Wednesday's Intraday Session

PomDoctor Limited Delays Annual 20-F Filing

12 Health Care Stocks Moving In Tuesday's Pre-Market Session